A Class II FDA recall has been issued for Omnicell i.v.STATION syringe labels following reports of system detection failures that compromise medication labeling accuracy. This classification reflects a serious safety concern requiring immediate attention from healthcare facilities nationwide.
According to the Institute for Safe Medication Practices, labeling errors are among the leading causes of medication administration mistakes in hospital settings. The affected automated compounding systems are widely used in critical care environments where precise drug identification is essential for patient safety. The system failure mechanism prevents proper label recognition, creating a pathway for mislabeled medications to enter clinical workflows.
Healthcare facilities using these systems must implement enhanced verification protocols immediately while Omnicell works toward a permanent solution. Read the full article on GMJ Newsroom.
Was this article helpful?
